Delivery Order SPE2DB20D3101-SPE2DB25FRKJ3

Award Date 5/15/25
Potential Completion Date 6/6/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,485.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,886,444 vials of the drug ZILRETTA 32 MG. The contract has a period of performance through May 2, 2025 and was awarded on April 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $1,857.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,246,627 vials of the drug ZILRETTA 32 MG. The contract has a period of performance through June 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,172,615 units of ZILRETTA 32 MG VIALS. The contract has a ceiling value of $2,228.94 and a performance period ending on May 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,457.88 firm fixed-price delivery order is for the supply of 4,568,236,556 vials of the medication ZILRETTA 32 MG. The contract has a performance period extending through June 4, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.96, is for the delivery of ZILRETTA 32 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
The Defense Logistics Agency (DLA) awarded a $1,114.47 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 32 mg vials of ZILRETTA, a pharmaceutical product. The contract has a completion date of January 24, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.96 firm fixed-price delivery order is for 32 mg vials of the medication ZILRETTA, with a period of performance through April 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,086.39, is for the delivery of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance through May 6, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.90 firm fixed price delivery order is for the supply of 4,568,152,966 units of ZILRETTA 32 MG VIALS. The contract has an ultimate completion date of May 28, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,144,491 units of ZILRETTA 32 MG VIALS, with a potential value of $7,621.56. The order has a completion date of January 11, 2024 and was awarded on December 19, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRKJ3
    Delivery Order

This is a $1,485.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,263,322 vials of ZILRETTA 32 MG, with an ultimate completion date of June 6, 2025. The contract is not set aside and is open to full and open competition.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader support of military and veteran healthcare systems through the IDC contract.

Generated 8/14/25, 9:56 AM